Lindsay Sulzer

Lindsay Sulzer, PhD, Chief Technology Officer, has 15 years of research experience in regenerative medicine relevant to multiple clinical applications. As a member of the TeVido team since 2013, she has established protocols for isolating and expanding epidermal cells and improved a hydrogel prototype for cellular therapy delivery for vitiligo. In her current role, she focuses on optimizing the cell isolation and storage procedures, developing appropriate quality tests and systems, determining necessary facilities and equipment, procuring high quality raw materials, and validating all components of the process. During graduate work at Northwestern University she created a tissue engineered hydrogel for transplanting islet cells and tracking the degradation in vivo via novel MRI contrast agents. At the University of Zurich, during her post-doctoral research, she developed hydrogels for bone and intervertebral disc regeneration that included delivery of both small molecule and protein-based therapeutics. She has a BS in Chem. E. from Princeton University. She has extensive experience in biomaterials, and a wide range of analytical and laboratory techniques.

Dr. Sulzer’s history as a process engineer at Intel provides valuable expertise in specialty product manufacturing, including clean room standards, equipment troubleshooting, root cause analysis, quality control, cost management, implementing standard operating procedures, technician training, and maintaining equipment to specifications.